Claudia Schormann
Homburg, SL, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Plasmacytic markers as immunotherapeutic targets for primary CD20-negative aggressive B-cell lymphomas.
Journal: British journal of haematology
Published: February 18, 2026
Fura-10, unlike fura-2, is suitable for long-term calcium imaging in natural killer (NK) cells without compromising cytotoxicity and can be combined with target cell death analysis.
Journal: Cell calcium
Published: October 02, 2025
Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms.
Journal: Nature communications
Published: March 13, 2025
CD16+ as predictive marker for early relapse in aggressive B-NHL/DLBCL patients.
Journal: Molecular cancer
Published: June 20, 2024
Autoantibodies against SUMO1-DHX35 in long-COVID.
Journal: Journal of translational autoimmunity
Published: November 13, 2022
Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphoma.
Journal: Haematologica
Published: October 28, 2019
Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicity.
Journal: Cancer immunology, immunotherapy : CII
Published: December 15, 2017
CD4⁺ T cells in chronic autoantigenic stimulation in MGUS, multiple myeloma and Waldenström's macroglobulinemia.
Journal: International journal of cancer
Published: August 29, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026